Onassis Holdings Corp. is a wellness and biotech holding company, specializing in healthcare, technology, and epigenetic reprogramming for rejuvenation. It is focused on marketing and distributing nutraceutical products and the licensing and commercialization of anti-aging technology. It has a subsidiary in Israel, working with scientific research companies in Europe, Israel, and the United States to carry out new drug preclinical/clinical research and safety studies to help with product development and practical applications. Its principal products/services include CimetrA-IMP, Co-Blox, Majestix, Majestix Post, ArtemiC Rescue, vapes, and vitamins and plant extracts. CimetrA-IMP is an investigational medicinal product which is in an urgent registration process in the United States to treat Covid-19. Co-Blox is a food supplement capsule to boost the immune system. Majestix is a syrup made of 15 plant extracts. Majestix Post is a syrup made of 15 plant extracts, vitamins and fungus.